Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
RD13-02
i
Other names:
RD13-02
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Nanjing Bioheng Biotech
Drug class:
CD7-targeted CAR-T immunotherapy
Related drugs:
‹
4SCAR7U (0)
Autologous CAR-T cells (0)
BEAM-201 (0)
BT-007 (0)
CD7 CAR-T (0)
CD7 CAR-T Cell (0)
CD7-CAR-T (0)
CD7-UCAR-γδT cells (0)
CTD401 (0)
GC027 (0)
GC502 (0)
SENL101 (0)
ThisCART7 (0)
WU CART 007 (0)
anti-CD7 CAR-T cell therapy (0)
autologous CD7-CAR T cells (0)
4SCAR7U (0)
Autologous CAR-T cells (0)
BEAM-201 (0)
BT-007 (0)
CD7 CAR-T (0)
CD7 CAR-T Cell (0)
CD7-CAR-T (0)
CD7-UCAR-γδT cells (0)
CTD401 (0)
GC027 (0)
GC502 (0)
SENL101 (0)
ThisCART7 (0)
WU CART 007 (0)
anti-CD7 CAR-T cell therapy (0)
autologous CD7-CAR T cells (0)
›
Associations
News
Trials
Filter by
Latest
1m
CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia (clinicaltrials.gov)
P1, N=15, Not yet recruiting, Institute of Hematology & Blood Diseases Hospital, China
1 month ago
New P1 trial
|
cyclophosphamide • RD13-02
over1year
Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma (clinicaltrials.gov)
P1, N=35, Not yet recruiting, Zhao Weili
over 1 year ago
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
RD13-02
over1year
RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies (clinicaltrials.gov)
P1, N=10, Recruiting, Henan Cancer Hospital
over 1 year ago
New P1 trial
|
CD7 (CD7 Molecule)
|
RD13-02
over1year
Research Development(RD)13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7(CD7)+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) (clinicaltrials.gov)
P1, N=18, Recruiting, Kai Lin Xu,MD
over 1 year ago
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
RD13-02
over1year
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL (clinicaltrials.gov)
P1, N=12, Recruiting, Xiaoyu Zhu
over 1 year ago
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
RD13-02
over1year
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies (clinicaltrials.gov)
P1, N=18, Recruiting, MEI HENG
over 1 year ago
New P1 trial
|
CD7 (CD7 Molecule)
|
RD13-02
almost2years
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL (clinicaltrials.gov)
P1, N=22, Recruiting, He Huang
almost 2 years ago
New P1 trial • CAR T-Cell Therapy
|
CD7 (CD7 Molecule)
|
RD13-02
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login